OpenAlex
Early loss of endogenous NAD+ following rotenone treatment leads to mitochondrial dysfunction and Sarm1 induction that is ameliorated by PARP inhibition
Work
Year: 2022
Type: article
Cites: 66
Cited by: 4
Related to: 10
FWCI: 0.705
Citation percentile (by year/subfield): 64.49
Subfield: Epidemiology
Field: Medicine
Sustainable Development Goal Good health and well-being
Open Access status: closed
Grant IDS BT/PR10983/BRB/10/1282/2014, CRG/2020/001325